Primary Dysmenorrhea

·MeSH: Dysmenorrhea

7 drugs in development·6 companies·2 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
celecoxib	Zomedica Corp. (ZOMDF)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	Miromatrix Medical Inc. (MIRO)
celecoxib	AlphaTON Capital Corp (ATON)
celecoxib	Aptinyx Inc. (APTX)
diclofenac	Zomedica Corp. (ZOMDF)

Phase 3(1)

Drug	Company
Xeomin	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 7 drugs in development for Primary Dysmenorrhea across 6 companies.

There are 2 clinical trials targeting Primary Dysmenorrhea tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.